Process Development Improvements Post-Pandemic

Article

What can the biopharma industry learn from its rapid response to the COVID-19 pandemic?

In this expert interview with BioPharm International, James Blackwell, president of The Windshire Group, LLC, explains key actions the biopharma can learn from its response to the COVID-19 pandemic that can be applied to improve process development for non-pandemic development programs.

Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
Related Content
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Entos Collaborates with Circio to Develop In-Vivo Delivery of DNA Vectors

Feliza Mirasol
April 10th 2025
Article

Through this collaboration, Circio will combine its circVec DNA vectors with Entos’ Fusogenix PLV delivery technology, which is expected to enhance delivery efficiency and reduce toxicity.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

A digital illustration depicting two DNA strands bound together by a red knot, symbolizing the intricate connections and complexities within the human genome. | Image Credit: ©Cooperr - stock.adobe.com

Challenges to the Development of Emerging Therapies

Cynthia A. Challener
April 8th 2025
Article

Hurdles exist across all aspects and phases of drug development and manufacturing.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

INTERPHEX 2025: Critical Role of Walk-In Chambers in Bio/Pharma Development and Manufacturing

INTERPHEX 2025: Critical Role of Walk-In Chambers in Bio/Pharma Development and Manufacturing

Patrick Lavery;Feliza Mirasol
April 3rd 2025
Article

Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, sat down with the PharmTech Group at INTERPHEX 2025 to discuss the design and critical role of walk-in chambers in the bio/pharmaceutical industry.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

At INTERPHEX 2025, Culture Biosciences Launches Cloud-Integrated Mobile Bioreactor

Patrick Lavery
April 1st 2025
Article

The company said the Stratyx 250 is the first bioreactor of its kind to offer biotech companies a combination of automation, remote process control, and flexibility.

© 2025 MJH Life Sciences

All rights reserved.